Debt 変化する 日付
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
BioCryst Pharmaceuticals USD 833.18M 13.88M 2023-09
Chugai Pharma JPY 14.11B 14.11B 2022-12
Daiichi Sankyo JPY 101.9B 41.09B 2023-09
DBV Technologies USD 0 0 2022-06
Enanta Pharmaceuticals USD 1.42M 0 2023-09
Gilead Sciences USD 24.98B 264M 2023-09
GlaxoSmithKline GBP 20.84B 638M 2023-09
Incyte USD 32.6M 678K 2023-12
Intra Cellular Therapies USD 0 0 2022-06
Ionis Pharmaceuticals USD 1.27B 14.67M 2023-12
Neurocrine Biosciences USD 169.9M 200K 2023-09
Novavax USD 222.11M 23.17M 2023-09
PTC Therapeutics USD 2.12B 762.21M 2023-12
Regeneron Pharmaceuticals USD 2.7B 300K 2023-12
Roche Holding CHF 25.39B 35M 2023-06
Sarepta Therapeutics USD 1.24B 1.24M 2023-09
Ultragenyx Pharmaceutical USD 0 0 2022-06
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09



BioCryst Pharmaceuticals 負債 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Mar 2024.